The computational medicine and drug discovery software market has been extensively studied based on several differentiating parameters to provide a comprehensive overview. The market has been segmented based on following parameters: tools, application and geography. Each of the categories has been further segregated into specific sub-divisions to consider the dynamics associated with this industry. Based on tools, software remained pre-dominant choice in 2015 followed by database. The applications considered in the report include computational physiological medicine, drug discovery and development, medical imaging, disease modeling, predictive analysis of drug targets, cellular simulation and simulation software. A similar strategy was followed to investigate the industry dynamics for computational medicine and drug discovery software specific to eminent countries that constituted the overall regional market including Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).
In 2015, the market share for medical imaging was 38.3% and is projected to grow at a CAGR of 4.2% during the forecast period. The main driving factor for the market are rising bioinformatics in drug discovery, three dimensional drug discovery methodology evolution and increase in late stage drug discovery failure.
Some of the established players in the market include:
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Global Computational Medicine and Drug Discovery Software Market Landscape
3.1. Market share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financial Analysis
4. Global Computational Medicine and Drug Discovery Software - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Computational Medicine and Drug Discovery Software Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers & Distributors
6. Global Computational Medicine and Drug Discovery Software Market – By Tools
7. Global Computational Medicine and Drug Discovery Software Market – By Application
7.2. Computational Physiological Medicine
7.3. Drug Discovery and Development
7.4. Medical Imaging
7.5. Disease Modelling
7.6. Predictive Analysis of Drug Targets
7.7. Cellular Simulation
7.8. Simulation Software
8. Global Computational Medicine and Drug Discovery Software Market – By Geography
8.2. North America
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, Partnerships & JVs
10. Investment Opportunities
11. Company Profiles
11.1. Aurora Fine Chemicals LLC
11.2. Biognos AB
11.3. Certara, L.P.
11.4. Chemical Computing Group Inc.
11.5. CLC bio
11.6. Collaborative Drug Discovery, Inc.
11.7. Compugen Ltd.
11.8. Crown Bioscience Inc.
11.9. Dassault Systemes, BIOVIA Corp.
11.10. Domainex Ltd
11.11. Entelos, Inc.
11.12. Genedata AG
11.13. Leadscope, Inc.
11.14. Nimbus Therapeutics
11.15. Prosarix Ltd
11.16. Quant Med LLC
11.17. Quantum Pharmaceuticals
11.18. Rhenovia Pharma Limited
11.19. Simulations Plus, Inc.
11.20. Schrödinger, LLC
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12.3. Research Methodology
12.5. Compilation of Expert Insights